The office management of recalcitrant rhinosinusitis

Otolaryngologic Clinics of North America

Volumn 37, Issue 2, 2004, Pages 365-379

  Zacharek, Mark A ^a   Hwang, Peter H ^a   Fong, Karen J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BECLOMETASONE DIPROPIONATE; BETA LACTAM ANTIBIOTIC; BUDESONIDE; CD4 ANTIGEN; CD8 ANTIGEN; CLINDAMYCIN; CYTOKINE; FLUNISOLIDE; FLUTICASONE; IMMUNOGLOBULIN E; MACROLIDE; METRONIDAZOLE; MOMETASONE FUROATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIAMCINOLONE;

ALLERGY; ANTIBIOTIC THERAPY; BACTERIAL OVERGROWTH; BACTERIUM CULTURE; CILIARY MOTILITY; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DIAGNOSTIC APPROACH ROUTE; FIBERSCOPE ENDOSCOPY; GOBLET CELL; HAEMOPHILUS INFLUENZAE; HUMAN; HYPEREOSINOPHILIA; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; MORAXELLA CATARRHALIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REVIEW; RHINOSINUSITIS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; HUMANS; SINUSITIS;

EID: 1842477161     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(03)00170-1     Document Type: Review

References (60)

1. Senior B.A., Kennedy D.W., Tanabodee J., et al. Long-term results of functional endoscopic sinus surgery. Laryngoscope. 108:(2):1998;151-157.
2. Christodoulopoulos P., Cameron L., Durham S., et al. Molecular pathology of allergic disease II: upper airway disease. J Allergy Clin Immunol. 105:2000;211-223.
3. Kalcioglu M.T., Durmaz B., Aktas E., et al. Bacteriology of chronic maxillary sinusitis and normal maxillary sinuses: using culture and multiplex polymerase chain reaction. Am J Rhinol. 17:(3):2003;143-147.
4. Brook I., Yocum P., Shah K. Aerobic and anaerobic bacteriology of concurrent chronic otitis media with effusion and chronic sinusitis in children. Arch Otolaryngol Head Neck Surg. 126:(2):2000;174-176.
5. Caplan E.S., Hoyt N.J. Nosocomial sinusitis. JAMA. 247:(5):1982;639-641.
6. Kennedy D.W., Senior B.A., Gannon F.H., et al. Histology and histomorphometry of ethmoid bone in chronic rhinosinusitis. Laryngoscope. 108: (4 Pt 1):1998;502-507.
7. Khalid A.N., Hunt J., Perloff J.R., et al. The role of bone in chronic rhinosinusitis. Laryngoscope. 112:(11):2002;1951-1957.
8. Ponikau J.U., Sherris D.A., Kern E.B., et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 74:1999;877-884.
9. Schubert M.S. A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusits, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol. 87:2001;181-188.
10. Hamilos D., Leung D., Wood R., et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte- macrophoage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol. 92:1993;39-48.
11. Al-Ghamdi K., Ghaffar O., Small P., et al. Il-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and the effect of topical corticosteroid treatment. J Otolaryngol. 26:1997;160-166.
12. Nayak D.R., Balakrishnan R., Murty K.D. Endoscopic physiologic approach toallergy-associated chronic rhinosinusitis: a preliminary study. Ear Nose Throat J. 80:(6):2001;390-403.
13. Krouse J.H. Computed tomography stage, allergy testing, and quality of life in patients with sinusitis. Otolaryngol Head Neck Surg. 123:2000;389-392.
14. Stewart M.G., Donovan D.T., Parke R.B. Jr., et al. Does the severity of sinus computed tomography findings predict outcome in chronic sinusitis? Otolaryngol Head Neck Surg. 123:2000;81-84.
15. Senior B.A., Kennedy D.W., Tanabodee J., et al. Long-term impact of functional endoscopic surgery on asthma. Otolaryngol Head Neck Surg. 121:(1):1999;66-68.
16. Lanza D.D., Kennedy D.W. Adult rhinosinusitis defined. Otorhinolaryngol Head Neck Surg. 117:1997;S1-S7.
17. Slack C.L., Dahn K.A., Abzug M.J., et al. Antibiotic-resistant bacteria in pediatric chronic sinusitis. Pediatr Infect Dis J. 20:(3):2001;247-250.
18. Hartog B., Degener J.E., VanBenthen P.T.G., et al. Microbiology of chronic maxillary sinusitis in adults: isolated aerobic and anaerobic bacteria and their susceptibility to twenty antibiotics. Acta Otolaryngol (Stockh). 115:1995;672-677.
19. Pfaller M.A., Ehrhardt A.F., Jones R.N. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Am J Med. 17:(111 Suppl 9A):2001;4S-12S. discussion 36S-38S.
20. Tantilipikorn P., Fritz M., Tanabodee J., et al. A comparison of endoscopic culture techniques for chronic rhinosinusitis. Am J Rhinol. 16:(5):2002;255-260.
21. Hwang P.H., Montone K.T., Gannon F.H., et al. Applications of in situ hybridization techniques in the diagnosis of chronic sinusitis. Am J Rhinol. 13:(5):1999;335-338.
22. Buchman C.A., Yellon R.F., Bluestone C.D. Alternative to endoscopic sinus surgery in the management of pediatric chronic rhinosinusitis refractory to oral antimicrobial therapy. Otolaryngol Head Neck Surg. 120:(2):1999;219-224.
23. Gross N.D., McInnes R.J., Hwang P.H. Outpatient intravenous antibiotics for chronic rhinosinusitis. Laryngoscope. 112:(10):2002;1758-1761.
24. Vaughn W.C., Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolarygol Head Neck Surg. 127:(6):2002;558- 568.
25. Scheinberg P.A., Otsuji A. Nebulized antibiotics for the treatment of acute exacerbations of chronic rhinosinusitis. Ear Nose Throat J. 81:(9):2002;648-652.
26. Ramsey B.W. Drug therapy: management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 335:(3):1996;179-188.
27. Ricchetti A., Landis B.N., Maffioli A., et al. Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol. 116:(4):2002;261-263.
28. Ponikau J.U., Sherris D.A., Kita H., et al. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol. 110:(6):2002;862-866.
29. Ramadan H.H., Hinerman R.A. Smoke exposure and outcome of endoscopic sinus surgery in children. Otolaryngol Head Neck Surg. 127:(6):2002;546-548.
30. Ferguson B.J. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope. 110:2000;799-813.
31. Lavigne F., Cameron L., Renzi P.M., et al. Intrasinus administration of topical budenoside to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope. (112):2002;858-864.
32. Kalogjera L., Vagic D., Baudoin T. Effect of endosinus treatment on cellular markers in mild and moderate asthmatics. Acta Otolaryngol. 123:(2):2003;310-313.
33. Lanier B.Q. Newer aspects in the treatment of pediatric and adult asthma: monoclonal anti-IgE. Ann Allergy Asthma Immunol. 90:(6 Suppl 3):2003;13-15.
34. Berger W., Gupta N., McAlary M. Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma. Ann Allergy Asthma Immunol. 91:(2):2003;182-188.
35. Corren J., Casale T., Deniz Y., et al. Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. Allergy Clin Immunol. 111:(1):2003;87-90.
36. Finn A., Gross G., van Bavel J., et al. Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. J Allergy Clin Immunol. 111:(2):2003;278-284.
37. Kopp M.V., Brauburger J., Riedinger F., et al. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis. J Allergy Clin Immunol. 110:(5):2002;728-735.
38. Chervinsky P., Casale T., Townley R., et al. Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 91:(2):2003;160-167.
39. Borish L.C., Nelson H.S., Lanz M.J., et al. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med. 160:(6):1999;1816-1823.
40. Bryan S.A., O'Connor B.J., Matti S., et al. Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 356:2000;2149-2153.
41. Steinke J.W., Bradley D., Arango P., et al. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma. J Allergy Clin Immunol. 111:(2):2003;342-349.
42. de Graaf in ten Veld C., Garrelds I.M., Koenders S., et al. Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls. Clin Exp Allergy. 26:1996;903-908.
43. Bisgaard H., Olsson P., Bende M. Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretions in humans. Clin Allergy. 16:1986;289-297.
44. Philip G., Malmstrom K., Hampel F.C., et al., Montelukast Spring Rhinitis Study Group. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy. 32:(7):2002;1020-1028.
45. Sousa A.R., Parikh A., Scadding G., et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 347:(19):2002;1493-1499.
46. Stevenson D.D., Simon R.A., Mathison D.A., et al. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol. 85:(6 Pt 1):2000;477-482.
47. Pauls J.D., Simon R.A., Daffern P.J., et al. Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol. 85:(1):2000;40-45.
48. Fujita K., Shimizu T., Majima Y., et al. Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells. Eur Arch Otorhinolaryngol. 257:(4):2000;199-204.
49. Suzuki H., Asada Y., Ikeda K., et al. Inhibitory effect of erythromycin on interleukin-8 secretion from exudative cells in nasal discharge of patients with chronic sinusitis. Laryngoscope. 109:1999;407-410.
50. Suzuki H., Shimomura A., Ikeda K., et al. Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients. Tohoku J Exp Med. 182:1997;115-124.
51. Anderson R., Theron A.J., Feldman C. Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils. Inflammation. 20:1996;693-705.
52. Wallwork B., Coman W., Feron F., et al. Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope. 112:2002;1827-1830.
53. Cazzola M., Salzillo A., Diamare F. Potential role of macrolides in the treatment of asthma. Monaldi Arch Chest Dis. 55:2000;231-236.
54. Tsang K.W., Ho P.I., Chan K.N., et al. A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J. 13:1999;361-364.
55. Chee L., Graham S.M., Carothers D.G., et al. Immune dysfunction in refractory sinusitis in a tertiary care setting. Laryngoscope. 111:(2):2001;233-235.
56. Hytonen M., Patjas M., Vento S.I., et al. Cystic fibrosis gene mutations deltaF508 and 394delTT in patients with chronic sinusitis in Finland. Acta Otolaryngol. 121:(8):2001;945-947.
57. Feldmann D., Couderc R., Audrezet M.P., et al. CFTR genotypes in patients with normal or borderline sweat chloride levels. Hum Mutat. 22:(4):2003;340.
58. Raynor E.M., Butler A., Guill M., et al. Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis. Arch Otolaryngol Head Neck Surg. 126:(5):2000;581-583.
59. Rayner C.F., Rutman A., Dewar A., et al. Ciliary disorientation alone as a cause of primary ciliary dyskinesia syndrome. Am J Respir Crit Care Med. 154:1996;1123-1129.
60. Toffel P.H., Christensen J. Epstein-Barr virus-mild acquired immune deficiency syndrome (EBV-MAIDS) in postsurgical sinusitis. Am J Rhinol. 16:(6):2002;291-295.